Disparities in Coronavirus Disease 2019 Clinical Outcomes and Vaccination Coverage Among Migrants With Human Immunodeficiency Virus in the PISCIS Cohort: A Population-Based Propensity Score-Matched Analysis

COVID-19; Migrants; VaccinationCOVID-19; Migrantes; VacunaciónCOVID-19; Migrants; VacunacióBackground: Coronavirus disease 2019 (COVID-19) disproportionately affects migrants and ethnic minorities, including those with human immunodeficiency virus (HIV). Comprehensive studies are needed to understand the impact and risk factors. Methods: Using data from the PISCIS cohort of people with HIV (PWH) in Catalonia, Spain, we investigated COVID-19 outcomes and vaccination coverage. Among 10 640 PWH we compared migrants and non-migrants assessing rates of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing, diagnosis, and associated clinical outcomes through propensity score matching and multivariable Cox regression. Results: The cohort (mean age, 43 years; 83.5% male) included 57.4% (3053) Latin American migrants. Migrants with HIV (MWH) had fewer SARS-CoV-2 tests (67.8% vs 72.1%, P < .0001) but similar COVID-19 diagnoses (29.2% vs 29.4%, P = .847) compared to Spanish natives. Migrants had lower complete vaccination (78.9% vs 85.1%, P < .0001) and booster doses (63.0% vs 65.5%, P = .027). COVID-19 hospitalizations (8.1% vs 5.1%, P < .0001) and intensive care unit (ICU) admissions (2.9% vs 1.2%, P < .0001) were higher among migrants, with similar hospitalization duration (5.5 vs 4.0 days, P = .098) and mortality (3 [0.2%] vs 6 [0.4%], P = .510). Age ≥40 years, CD4 counts <200 cells/μL, ≥2 comorbidities, and incomplete/nonreception of the SARS-CoV-2 vaccine increased the risk of severe COVID-19 among migrants. Conclusions: MWH had lower rates of SARS-CoV-2 testing and vaccination coverage, although the rates of COVID-19 diagnosis were similar between migrants and non-migrants. Rates of COVID-19-associated hospitalizations and ICU admissions were higher among migrants in comparison with non-migrants, with similar hospitalization duration and mortality. These findings can inform policies to address disparities in future pandemic responses for MWH.This work was supported by the Fundació La Marató de TV3 (grant number 202117-30-31) and a personal 80:20 research grant from Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain, during 2017–2024 to J. M.

Avaluació poblacional de la infecció per SARS-CoV-2 entre les persones que viuen amb el VIH i la població general de Catalunya (març – desembre 2020)

Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; VIH; Avaluació poblacionalCoronavirus SARS-CoV-2; COVID-19; 2019-nCoV; VIH; Avaluación poblacionalCoronavirus SARS-CoV-2; COVID-19; 2019-nCoV; VIH; Population assessmentEn aquest estudi s’analitza la influència de la infecció pel SARS-Cov-2 sobre el diagnòstic i la gravetat de la infecció pel VIH

Chocó bio-innovador y sustentable

La formulación del Plan Estratégico Regional en Ciencia, Tecnología e Innovación del departamento del Chocó (PERCTI) tiene como propósito central señalar el camino para fortalecer el desarrollo propio e intercambio de mejores prácticas en sectores claves; reconocer la formación de expertos en áreas temáticas priorizadas; fortalecer la capacitación del talento humano mediante el aprovechamiento de capacidades instaladas en el territorio; coadyuvar a la transferencia de tecnologías necesarias para impulsar el desarrollo endógeno sustentable y, por supuesto, incentivar la incorporación de conocimiento científico y tecnológico en la cotidianidad de las personas para mejorar su calidad de vida